FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

REAADS VON WILLEBRAND FACTOR ACTIVITY TEST KIT, MODEL 10826

K Number: K032139 · Decision Apr 5, 2004
Classifications
1
FEI Numbers
21
Registration Numbers
21
Same Product Code
189
Applicant Total
23
Review Days
269

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
REAADS VON WILLEBRAND FACTOR ACTIVITY TEST KIT, MODEL 10826
K Number
K032139
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
864.7290
Medical Specialty
Hematology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Corgenix, Inc.
Date Received
July 11, 2003
Decision Date
April 5, 2004
Product Code
GGP
Advisory Committee
Hematology
Review Advisory Committee
HE
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
GGP Test, Qualitative And Quantitative Factor Deficiency

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (GGP), ordered by most recent decision date.

View all

Other Clearances by Corgenix, Inc.

K Number Device Name
K072032 IGG ANTI-ATHEROX TEST KIT
K062025 ASPIRINWORKS TEST KIT (11-DEHYDRO THROMBOXANE B2), MODEL 12136
K042680 RHIGENE HEP-ANA TEST SYSTEM
K034013 REAADS DSDNA QUANTITATIVE TEST KIT, MODEL 022-001
K032868 REAADS II ANTI-CARDIOLIPIN IGG SEMI-QUANTITATIVE TEST KIT, MODEL 11139
K031208 REAADS IGM ANTI-B2GPI TEST KIT, MODEL 038-001
K024196 REEADS ANTI-PHOSPHATIDYLSERINE IGG/IGM SEMI-QUANTITATIVE TEST KIT
K024195 MODIFICATION TO REAADS ANTI-PHOSPHATIDYLSERINE IGA SEMI-QUANTATIVE TEST KIT
K022990 REAADS IGA ANTI-CARDIOLIPIN SEMI-QUANTITATIVE TEST KIT, MODEL 026-001
K022992 REAADS ANTI-CARDIOLIPIN IGG/IGM SEMI-QUANTITATIVE TEST KIT, MODEL 023-001
Search all 23 clearances from Corgenix, Inc. →